Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.
<h4>Background</h4>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events dur...
Main Authors: | Arie Passov, Alexey Schramko, Ulla-Stina Salminen, Juha Aittomäki, Sture Andersson, Eero Pesonen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0251747 |
Similar Items
-
Graft glycocalyx degradation in human liver transplantation.
by: Arie Passov, et al.
Published: (2019-01-01) -
The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
by: Arie Passov, et al.
Published: (2019-05-01) -
The endothelial glycocalyx and sepsis
by: Ashit Hegde
Published: (2015-01-01) -
Effect and safety of 4% albumin in the treatment of cardiac surgery patients: study protocol for the randomized, double-blind, clinical ALBICS (ALBumin In Cardiac Surgery) trial
by: Hanna Vlasov, et al.
Published: (2020-02-01) -
The role of endothelial glycocalyx in sepsis
by: I Nyoman Budi Hartawan, et al.
Published: (2019-01-01)